TVRD
Tvardi Therapeutics Inc
NASDAQ · Pharmaceuticals
$3.72
+0.17 (+4.79%)
Open$3.56
Previous Close$3.55
Day High$3.75
Day Low$3.50
52W High$41.62
52W Low$22.66
Volume—
Avg Volume567.9K
Market Cap34.90M
P/E Ratio12.98
EPS$2.55
SectorPharmaceuticals
Analyst Ratings
Buy
14 analysts
Price Target
+923.4% upside
Current
$3.72
$3.72
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 11.10M | 10.81M | 8.76M |
| Net Income | 2.81M | 2.98M | 1.76M |
| Profit Margin | 25.3% | 27.6% | 20.0% |
| EBITDA | 4.19M | 3.89M | 3.58M |
| Free Cash Flow | 2.70M | 2.37M | 1.91M |
| Rev Growth | -6.6% | +19.2% | +16.4% |
| Debt/Equity | 0.85 | 0.91 | 0.94 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |